This HTML5 document contains 140 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
n9http://dx.doi.org/10.1136/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41158708
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 1982 scienca artikolo artikel ilmiah 1982年论文 tudományos cikk bài báo khoa học 1982 nî lūn-bûn article scientifique 1982年論文 scientific article published on April 1982 1982년 논문 1982年論文 teaduslik artikkel научни чланак bilimsel makale vitenskapelig artikkel naučni članak artikulong pang-agham 1982年論文 научна статия Additive antianginal effect of verapamil in patients receiving propranolol. vedecký článok artigo científico 1982年论文 επιστημονικό άρθρο мақолаи илмӣ articol științific 1982年论文 scientific article published on April 1982 artykuł naukowy 1982年論文 บทความทางวิทยาศาสตร์ 1982年论文 wetenschappelijk artikel এপ্রিল ১৯৮২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel wissenschaftlicher Artikel наукова стаття, опублікована у квітні 1982 artikull shkencor videnskabelig artikel مقالة علمية نشرت في أبريل 1982 artigo científico 1982年论文 article scientific 1982年論文 სამეცნიერო სტატია scientific article published on April 1982 articolo scientifico vědecký článek научни чланак vetenskaplig artikel 1982年の論文 tieteellinen artikkeli научная статья artigo científico article científic 1982年论文 מאמר מדעי
p:P577
wds:Q41158708-137C85FA-6B40-44CA-8D92-0A2D96FD82B1
wdt:P577
1982-04-01T00:00:00Z
p:P407
wds:Q41158708-540480D6-CCE8-4AB8-85A0-F4E71C5CB23D
wdt:P407
wd:Q1860
p:P2860
wds:Q41158708-26E9E567-9A22-40FB-A67A-7358DF9C6D77 wds:Q41158708-02764AF8-ABA3-4399-8EF5-B7555D40A70B wds:Q41158708-07C11F6F-3AF8-4B23-8D93-61F1492CB06A wds:Q41158708-099927D1-187E-49E5-BC0C-3E1F599933AC wds:Q41158708-4110FA95-0699-44D2-A766-AF86811EAC52 wds:Q41158708-31982B4A-C744-42D9-9CC2-5A86F9A1EFCB wds:Q41158708-334A47E0-44BD-4BFF-B8DE-FA48E9B8971B wds:Q41158708-00C8BD30-8694-4EE7-926B-C06AC082BF00 wds:Q41158708-EFEDD2FC-9A4F-4344-BDEB-42C9804C1294 wds:Q41158708-F1993ED6-4659-430D-97AE-4B7FCC5F4CE7 wds:Q41158708-82759A56-DD6F-4DEA-A0EF-CB1C0E2E55CC wds:Q41158708-A26A82D8-F2D2-42E1-9B56-A6B05036B16A wds:Q41158708-AF1F46A4-6F56-4528-AA04-FE3B20067D0C wds:Q41158708-63C61937-17ED-4928-AEF6-4D4225401279 wds:Q41158708-6715C677-78A0-4816-BC2D-E1CAAAD92689 wds:Q41158708-719C48F7-6983-49C9-9632-3B30A8974E84 wds:Q41158708-D185D21E-F939-407E-BFF4-095C2514FF71 wds:Q41158708-DCA08E3E-AC0F-4478-9730-3F11E80478A9 wds:Q41158708-E5629660-430A-475F-A937-E203252BEF1C wds:Q41158708-E60BBD57-755F-4EF3-AFC2-3CD8C0D6C771 wds:Q41158708-C0762B0F-2EFE-46A9-9497-3DF15739A18A wds:Q41158708-C7094929-864A-4CEC-8833-5508FF190986 wds:Q41158708-CD5C2853-8185-4D84-8EA3-136F37D39376
wdt:P2860
wd:Q93825220 wd:Q28364433 wd:Q30865827 wd:Q40815878 wd:Q49244652 wd:Q36810365 wd:Q72606716 wd:Q70815400 wd:Q41204166 wd:Q57072038 wd:Q71423995 wd:Q36810369 wd:Q69986015 wd:Q72422581 wd:Q72422867 wd:Q28363540 wd:Q72045452 wd:Q72014827 wd:Q44542634 wd:Q66852409 wd:Q55043561 wd:Q40976702 wd:Q72421507
p:P2093
wds:Q41158708-29826CF8-18B6-40CC-B053-D03F42C3896F wds:Q41158708-2A036143-C125-4EAD-8FC0-CA6316C55FD9 wds:Q41158708-5C19B6BF-9E7C-4670-8EA3-0DC72322D2EB
wdt:P2093
M Bassan O Shalev D Weiler-Ravell
rdfs:label
Additive antianginal effect of verapamil in patients receiving propranolol.
skos:prefLabel
Additive antianginal effect of verapamil in patients receiving propranolol.
schema:name
Additive antianginal effect of verapamil in patients receiving propranolol.
p:P1476
wds:Q41158708-9C8F1343-8B93-407C-8478-84A64558499C
wdt:P1476
Additive antianginal effect of verapamil in patients receiving propranolol
p:P304
wds:Q41158708-F8B57083-1AF9-4163-B2F2-376157FF1F30
wdt:P304
1067-1070
p:P31
wds:Q41158708-3BC520A4-9ED4-40A4-901A-279577EC8CFF
wdt:P31
wd:Q13442814
p:P921
wds:Q41158708-F2EAD26D-02E3-473A-8968-11F375C31463
wdt:P921
wd:Q410291
p:P698
wds:Q41158708-5DC03E24-E9B1-43FB-ABB6-CBEF05662B09
wdtn:P698
n11:6802408
wdt:P698
6802408
p:P1433
wds:Q41158708-52E55EC3-408D-4062-8A53-22B9688CCD89
wdt:P1433
wd:Q546003
p:P433
wds:Q41158708-C3ADCBE2-15A1-4029-AC16-D63DDE75A1DC
p:P478
wds:Q41158708-1364DDD1-842F-4F31-9BA1-86A0BDA3F91A
wdt:P433
6322
wdt:P478
284
p:P356
wds:Q41158708-051272A1-0E7E-4007-BE01-9C06C5A00A91
wdtn:P356
n9:BMJ.284.6322.1067
wdt:P356
10.1136/BMJ.284.6322.1067
p:P932
wds:Q41158708-EE2E0A81-134A-492A-BD06-21C2D39E4A33
wdt:P932
1497925